✦ LIBER ✦
Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors
✍ Scribed by Kaumaya, P. T.P.; Foy, K. C.; Garrett, J.; Rawale, S. V.; Vicari, D.; Thurmond, J. M.; Lamb, T.; Mani, A.; Kane, Y.; Balint, C. R.; Chalupa, D.; Otterson, G. A.; Shapiro, C. L.; Fowler, J. M.; Grever, M. R.; Bekaii-Saab, T. S.; Carson, W. E.
- Book ID
- 121346841
- Publisher
- American Society of Clinical Oncology
- Year
- 2009
- Tongue
- English
- Weight
- 217 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.